跳至主要内容
临床试验/NCT04671979
NCT04671979已完成不适用

Lactate Dehydrogenase, Bowel Necrosis and Mortality in Acute Mesenteric Ischemia: Retrospective Cross-Sectional

Universidad del Rosario1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2017年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
1
主要终点
Bowel necrosis length in cm

研究概览

简要总结

Background: Acute mesenteric ischemia is a vascular emergency with high mortality because of ambiguous symptomatology and a lack of early diagnostic markers. Lactate dehydrogenase has been described as a mortality biomarker and bowel necrosis length too. Nevertheless, the association between them has been mildly studied. Our objective was to evaluate the association between serum lactate admission levels, bowel necrosis extension, and mortality. Additionally, we performed a mortality characterization.

Materials and Methods: A retrospective cross-sectional study was designed. We reviewed patients' clinical records with acute mesenteric ischemia that attended a hospital between 2012 and 2018. We compared serum lactate admission levels with bowel necrosis length and mortality. A receiver operating characteristic curve was performed on the last association. As post hoc analysis, a classification and regression tree on mortality was fitted.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Older than 18 years of age
  • Required urgent laparotomy with a postoperative diagnosis of acute mesenteric ischemia
  • Attended the private academic hospital, between 2012 and 2018
  • Had a registered serum lactate dehydrogenase at admission

排除标准

  • Secondary causes of AMI
  • Chronic intestinal ischemic
  • Patient records with no description of the serum lactate dehydrogenase or extension of intestinal necrosis

结局指标

主要结局

Bowel necrosis length in cm

时间窗: 30 days

Serum Lactate in mmol/l

时间窗: 30 days

Percentage of patients that died between 30 postsurgical days, %

时间窗: 30 days

次要结局

  • Cut value of lactate levels as a predictor of mortality, in mmol/l(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrés Isaza Restrepo

MD, MSc

Universidad del Rosario

研究点 (1)

Loading locations...

相似试验